Buy and Bill sounds simple. You purchase the medication, administer it in the clinic, submit a claim, and get reimbursed. In reality, this is where many Spravato programs struggle. Clinics start strong, see patient demand, invest in medication inventory, and then run into unexpected issues. Payments come in lower than expected. Claims get delayed. Inventory does not match revenue. Margins shrink without a clear explanation.
If you are working with Spravato Buy and Bill, understanding where money is made or lost is critical. Our Spravato Billing Services are designed to simplify this entire process so clinics maintain predictable margins as they grow.
Under the Buy and Bill model, the clinic:
Unlike pharmacy-based models, the financial responsibility sits with the provider.
This means your profitability depends on three things:
Even small inefficiencies across these areas create real financial impact.
Most revenue leakage does not come from one big mistake. It comes from small gaps that repeat across multiple treatments.
Drug pricing varies across distributors. Two clinics can administer the same treatment but operate with very different margins based on their purchase price. Without negotiation, many clinics pay more than necessary.
In high volume programs, even a small price difference per dose compounds quickly. Finnastra works with most major distributors to help clinics secure better pricing and stabilize margins.
Spravato reimbursement depends on accurate unit reporting. If units are underreported, you lose revenue. If overreported, claims are flagged or denied. This is one of the most common issues in Spravato Buy and Bill workflows.
A clinic may not notice the issue immediately, but over time it results in consistent underpayment. When you work with a dedicated Spravato Billing Company like Finnastra, drug units are validated against dosage before claims are submitted.
Many clinics assume that once prior authorization is approved, billing will be straightforward.
In reality, mismatches between authorization and billing create denials.
Examples include:
These gaps slow down reimbursement and increase rework.
As a leading Spravato Billing Services Company, Finnastra manages authorization alignment so claims are supported before submission.
Timing matters in Buy and Bill. You have already paid for the medication. Any delay in claim submission or processing directly affects cash flow.
Industry benchmarks show that practices with inefficient workflows often see 20% or more of claims delayed beyond standard payment cycles.
This creates pressure on inventory purchasing and limits program growth. Our Spravato Billing Services are designed to simplify claim turnaround and reduce days in accounts receivable.
Another issue clinics face is a disconnect between inventory usage and billing data.
This shows up as:
Without clear visibility, clinics cannot accurately measure performance.
Finnastra helps align inventory tracking with billing data so every dose administered is accounted for financially.
Consider a clinic performing 30 Spravato treatments per week.
If the clinic overpays by even $40 per dose due to poor distributor pricing, that is over $1200 per week in reduced margin.
If an additional 10% of claims are underpaid due to unit errors or coding gaps, the financial impact increases further.
Over a year, these small inefficiencies can result in tens of thousands in lost revenue.
This is why Buy and Bill requires more than basic billing support.
If these issues sound familiar, the problem is not demand. It is process.
Finnastra approaches Buy and Bill with a focus on margin protection.
As a Top Spravato Billing Company in U.S, Finnastra ensures:
Our Spravato Billing Services are designed to simplify complex workflows so clinics can focus on patient care while maintaining financial control.
When you work with a dedicated Spravato Billing Company like Finnastra, profitability is not left to chance. It is built into the process.
Spravato Buy and Bill can be highly profitable when managed correctly. It can also quietly erode margins when small issues go unnoticed.
The difference comes down to visibility, accuracy, and coordination.
Clinics that treat billing, inventory, and authorization as one connected system achieve stable growth. Clinics that manage them separately often face delays, denials, and reduced margins. If your Spravato program is growing or planning to scale, now is the time to evaluate how your Buy and Bill workflow is performing.
Finnastra supports practices across the United States with structured Spravato Billing Services that protect revenue and improve operational efficiency.
